Longstanding Phenytoin Use as a Cause of Progressive Dyspnea.
Chest
; 161(2): e91-e96, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1664780
ABSTRACT
CASE PRESENTATION A 54-year-old South African man with a medical history of type 2 diabetes mellitus, seizure disorder, OSA, and latent TB presented to the ER with gradually progressive dyspnea over months. He also reported occasional dry cough and fatigue at presentation but denied fever, chills, chest pain, leg swelling, palpitations, or lightheadedness. He was treated with a course of levofloxacin for presumed community-acquired pneumonia as an outpatient without improvement and had tested negative for COVID-19. He denied occupational or environmental exposures or sick contacts, though he had traveled back to South Africa 1 year before presentation. He had complex partial seizures for the past 22 years, which had been well controlled on phenytoin (300 mg daily). His other home medications included dulaglutide, sertraline, and atorvastatin and had no recent changes. He quit smoking 30 years ago after smoking one pack per day for 10 years.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Phenytoin
/
Seizures
/
Lung Diseases, Interstitial
/
Drug Substitution
/
Lacosamide
/
COVID-19
/
Lung
Type of study:
Case report
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Chest
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS